PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
02-Jun-2021 Positive update on microbiome therapeutic NTCD-M3 for recurrent C. difficile infections Destiny Pharma plc
02-Jun-2021 Tiziana Life Sciences plc ("Tiziana" or the “Company”) Posting of Notice of Annual General Meeting Tiziana Life Sciences
02-Jun-2021 Moderna Announces New Drug Substance Production Agreement with Lonza in the Netherlands Moderna
02-Jun-2021 MPH Health Care AG: result Q1-2021 MPH Health Care AG
02-Jun-2021 Kuros Biosciences’s commercial roll-out of MagnetOs bone graft exceeds expectations Kuros Biosciences AG
02-Jun-2021 Lonza and Moderna Announce Further Collaboration For Drug Substance Manufacturing of COVID-19 Vaccine Moderna in the Netherlands Lonza Group AG
02-Jun-2021 Biotest AG: Biotest successfully completes recruitment for its clinical trial with trimodulin in severe COVID-19 patients Biotest AG
02-Jun-2021 Relief Therapeutics Reports that its Collaboration Partner, NRx Pharmaceuticals, has Submitted an Application for Emergency Use Authorization for Aviptadil to the U.S. Food & Drug Administration RELIEF THERAPEUTICS Holdings AG
02-Jun-2021 Companion Diagnostics Market to Reach USD 6.8 billion by 2025 – Growing Significance in Drug Development MarketsandMarkets Research Private Ltd.
02-Jun-2021 Significant Growth Expected for Stem Cell Manufacturing Market MarketsandMarkets Research Private Ltd.
01-Jun-2021 Global Inactivated Vaccines Market Report Up to 2030 : Visiongain Research Ltd. Visiongain
01-Jun-2021 Almirall receives FDA approval to produce Seysara® (sarecycline) at the Sant Andreu de la Barca (Barcelona) plant Almirall
01-Jun-2021 “New Science” is Driving More Growth than Predicted Against a Changing Economic Environment, According to Accenture Report Accenture
01-Jun-2021 Santhera and ReveraGen Announce Positive and Statistically Highly Significant Topline Results with Vamorolone in Pivotal VISION-DMD Study Santhera and ReveraGen
01-Jun-2021 Lucida Medical receives CE marking for Pi, its AI-machine learning software for detecting prostate cancer from MRI, enabling faster and more accurate prostate cancer detection Lucida Medical
01-Jun-2021 EULAR 2021: New Data from UCB’s Rheumatology Portfolio Demonstrates Real World Value for Patients with axSpA, PsA, and Women of Childbearing Age UCB
01-Jun-2021 87% of Top 300 Pharma Companies in Europe and US have a Poor Digital Culture that Inhibits Innovation Aspen Technology
01-Jun-2021 COREX Logistics opens Kazakhstan office COREX Logistics
01-Jun-2021 Biotest AG: Ad-hoc RELEASE Announcement according to Article 17 European Market Abuse Regulation (MAR) Biotest AG
01-Jun-2021 Cytel Calls for Statistical Innovation to be Mobilized for Global Health Challenges Cytel Inc.